Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
06/2012
06/20/2012EP2464654A2 Thiol protecting group
06/20/2012EP1463942B2 Methods for purifying protein
06/20/2012CN102505034A Method for preparing active polypeptide from corn protein powder
06/20/2012CN102505033A Method for preparing lactoferricin and method for applying lactoferricin in bacterial inhibition of foods
06/20/2012CN102504019A Method for separating cecropin antimicrobial peptides
06/20/2012CN102504018A Melittin pamoate capable of being continuously released and preparation agent thereof
06/20/2012CN102504017A Novel Enterococcus and Streptococcus strains and bacteriocins
06/20/2012CN102504013A Target chemical drug PADM against cancer metastasis and preparation method and use thereof
06/20/2012CN102504012A Preparation method of fullerene reduced glutathione derivative
06/20/2012CN102504011A Method for separating and preparing potato protein powder from potato juice
06/20/2012CN102504010A Preparation method of micro-fluidic chip interface for two-dimensional protein electrophoretic separation
06/20/2012CN102504009A Production method of active boxthorn leaf albumen powder
06/20/2012CN102504008A Microballoon carrier with low degree of cross linking in solid-phase synthesis of polypeptide
06/20/2012CN101974070B Preparation process of human prothrombin compound
06/20/2012CN101967194B Recombinant human cell restin MHD fusion protein and preparation method thereof
06/20/2012CN101684151B Protein matter with coagulation activity
06/20/2012CN101633687B Preparation method and application of affinity-membrane filtration carrier for separating gene recombinant protein
06/20/2012CN101332292B Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain
06/19/2012US8202967 H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
06/19/2012US8202716 Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012US8202427 Porous ferro-or ferrimagnetic glass particles for isolating molecules
06/19/2012CA2314610C Method for preparing by filtration a virally secure factor viii solution
06/19/2012CA2312976C Compositions comprising histidine-linked protein polymer conjugates
06/14/2012WO2012078376A1 Ion exchange chromatography in the presence of an amino acid
06/14/2012WO2012077080A1 Compositions for separation methods
06/14/2012WO2012075570A1 Bioactive peptides and proteins containing bioactive peptides, their uses and processes for making the same
06/14/2012WO2012036973A3 Process for immobilization of candida antarctica lipase b
06/14/2012US20120151620 Chloroplast transit peptides for efficient targeting of dmo and uses thereof
06/14/2012US20120149885 Downstream bioprocessing device
06/14/2012US20120149884 Specific antibody selection by selective elution conditions
06/14/2012US20120149878 Protein purification
06/14/2012US20120149877 Tumor-specific recognition molecules
06/14/2012US20120149875 Affinity chromatography matrix
06/14/2012US20120149873 Method for purifying albumin
06/14/2012US20120149872 Channel-based purification device
06/14/2012US20120149868 Purification of peptides prepared by solid phase synthesis
06/14/2012US20120149636 Modified Leptin Polypeptides and Their Uses
06/14/2012US20120149591 In vitro peptide expression library
06/14/2012US20120149062 High Purity Lipopeptides
06/14/2012US20120148587 Polypeptide formulation
06/14/2012US20120148568 Variant Immunoglobulins with Improved Manufacturability
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148552 Method and compositions for enhanced anti-tumor effector functioning of t cells
06/14/2012US20120148526 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
06/14/2012US20120145544 Novel ubiquitin ligase and use thereof
06/14/2012CA2820861A1 Compositions for separation methods
06/13/2012EP2463299A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
06/13/2012EP2463293A1 Azacyclohexapeptide or its pharmaceutical acceptable salt, preparing method and use thereof
06/13/2012EP2462240A1 A lectin assay for assessing glycoforms as an early marker in disease
06/13/2012EP2462158A1 Method to improve virus removal in protein purification
06/13/2012EP2462157A1 Methods for purifying a target protein from one or more impurities in a sample
06/13/2012EP2124548B1 Disintegrin variants and pharmaceutical uses thereof
06/13/2012EP1849766B1 Beta-benzyloxyaspartic acid derivative having two substituents on benzene ring
06/13/2012EP0451216B2 Humanized immunoglobulins and their production and use
06/13/2012CN1759122B Methods and compositions involving MDA-7
06/13/2012CN1483831B Process for obtaining insulin and insulin derivatives having correctly bonded crystine bridges
06/13/2012CN102498124A Cyclic amino acid molecules and methods of preparing the same
06/13/2012CN102492758A Method for preparing Caspase-3 activation peptide by phycocyanin
06/13/2012CN102492714A Method for preparing recombinant Chinese rural dog interferon-alpha
06/13/2012CN102492658A PSer86 monoclonal antibody of Tip60, as well as preparation method and application of pSer86 monoclonal antibody
06/13/2012CN102492040A Method for purifying anti-HER2 or/and anti-HER3 antibody proteins
06/13/2012CN102492035A Preparation method for purifying yolk antibody
06/13/2012CN102492034A Rice field eel serum transferrin, preparation method and use thereof
06/13/2012CN102492027A Method for extracting Bt insecticidal protein crystal
06/13/2012CN102492024A Method for extracting daptomycin from fermentation broth
06/13/2012CN102492023A PLAC1 anti-tumour CTL epitope peptide and application thereof
06/13/2012CN102492021A Preparation process for bortezomib
06/13/2012CN102492020A Pidotimod compound and new preparation method thereof
06/13/2012CN102492016A Method for separation purification of nitrile hydratase regulatory protein
06/13/2012CN102492015A Extraction technology for Huidouba peptidoglycan
06/13/2012CN102491898A Method for simultaneously extracting chlorogenic acid and sunflower protein from sunflower seed meals
06/13/2012CN102489266A Medium and method for separating and purifying polyethylene glycol modifier
06/13/2012CN102161754B Functional modification method for branched polyethylene glycol (PEG) derivative
06/13/2012CN101830979B Method for separating and purifying serum albumin by using liquid-solid extraction system
06/13/2012CN101792490B Method for recycling albumin in Cohn's fraction IV precipitate
06/13/2012CN101775406B Recombinant protein expression and purification with functions of preventing and treating atherosclerosis
06/13/2012CN101570574B Anti-I type Shiga toxin IgY antibody as well as preparation method and use thereof
06/13/2012CN101280001B Preparation of human SDF-1 alpha, human SDF-1 alpha obtained therefrom and use thereof
06/13/2012CN101245104B Ocean cephalopod skin glue collagen and preparation method thereof
06/12/2012US8198404 Mutated immunoglobulin-binding protein
06/12/2012US8198218 Heterocyclic compounds, combinatorial libraries thereof and methods of selecting drug leads
06/12/2012US8198049 Nucleic acids encoding RUP3 and methods of using same
06/12/2012US8198031 Detecting and profiling molecular complexes
06/12/2012US8197821 Human immunodeficiency virus integrase—Transportin—SR protein—protein interactions
06/07/2012WO2012075361A2 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
06/07/2012WO2012075206A1 Deuterated peptides
06/07/2012WO2012074637A2 Methods for removing plasma
06/07/2012WO2012074463A1 Affinity chromatography matrix
06/07/2012WO2012071631A1 Improved light-emitting molecules
06/07/2012WO2012050874A3 Targeting heme for the treatment of immune mediated inflammatory diseases
06/07/2012WO2012044999A3 Reversible protein multimers, methods for their production and use
06/07/2012WO2012020080A3 Ligands for affinity chromatography
06/07/2012US20120142904 Protein renaturation microfluidic devices and methods of making and using the same
06/07/2012US20120142903 Methods For Detecting And Analyzing N-Glycolylneuraminic Acid (NEU5GC) In Biological Materials
06/07/2012US20120142901 Purification method which prevents denaturation of an antibody
06/07/2012US20120142898 Implantable material and a method for the preparation thereof
06/07/2012US20120142897 Phosphonates synthons for the synthesis of phosphonates derivatives showing better bioavailability
06/07/2012US20120142894 Identification, Optimization and Use of Shared HLA-B*0702 Epitopes for Immunotherapy
06/07/2012US20120142893 Separation and/or purification of b0 from c0
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 518